Atlas Trials

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

Clinical trial NCT04535752 · COMPLETED

Trial details

NCT number
NCT04535752
Sponsor
Annexon, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety and Tolerability in Healthy Volunteers
Start date
2020-10-30
Primary completion
2021-06-26
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.